Article info
PDFInflammatory bowel disease
Paper
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- Correspondence to Dr Saskia van Mil, UMC Utrecht, Lundlaan 6, Utrecht 3584 EA, The Netherlands; s.w.c.vanmil{at}umcutrecht.nl
Citation
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Publication history
- Revised October 15, 2010
- Accepted November 9, 2010
- First published January 17, 2011.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.